[{"Assets_0_Q1_USD":359545000.0,"CommonStockSharesOutstanding_0_Q1_shares":43091922.0,"NetIncomeLoss_1_Q1_USD":-21356000.0,"StockholdersEquity_0_Q1_USD":295499000.0,"Ticker":"NTLA","CIK":"1652130","name":"INTELLIA THERAPEUTICS, INC.","OfficialName":"Intellia Therapeutics Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4259315236.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20180501"}]